MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$800,382K
Non Us
$165,183K
Revenue From Contract
With Customer...
$898,731K
Net (loss) income
-$713,410K
(-403.27%↓ Y/Y)
Pmo Products
$965,565K
Elevidys
$898,731K
(loss) income before
income tax expense
-$702,225K
(-369.28%↓ Y/Y)
Income tax expense
$11,185K
(-56.20%↓ Y/Y)
Products, net
$1,864,296K
(4.27%↑ Y/Y)
Collaboration and other
$333,941K
(192.88%↑ Y/Y)
Operating (loss) income
-$699,781K
(-420.88%↓ Y/Y)
Total other (loss)
income, net
-$2,444K
(-105.72%↓ Y/Y)
Total revenues
$2,198,237K
(15.58%↑ Y/Y)
Gain (loss) on debt
extinguishment
$16,862K
Total cost and
expenses
$2,898,018K
(72.10%↑ Y/Y)
Other (expense)
income, net
-$19,306K
(-145.22%↓ Y/Y)
Research and development
$1,522,066K
(89.19%↑ Y/Y)
Cost of sales
(excluding amortization of...
$839,605K
(163.12%↑ Y/Y)
Selling, general and
administrative
$491,716K
(-11.86%↓ Y/Y)
Restructuring charge
$42,009K
Amortization of in-licensed
rights
$2,622K
(9.02%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)
logo (1) copy-svg
Sarepta Therapeutics, Inc. (SRPT)